Novo CEO pressed by Senate to cut price ranges of being overweight, diabetes medicine CEO Lars Fruergaard Jørgensen advised lawmakers the company would take into account new talks with insurers about the listing prices of Wegovy and copyright when they pledge to maintain the medicines on their formularies. Since some https://kethek.com/